CAREFUSION 303, INC.

Manufacturer adverse-event records for CAREFUSION 303, INC. come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2010–2026 · heavy-book · quiet Death-code · injury-light

Injury-mix signature

CAREFUSION 303, INC. is lighter on Injury codes

Injury-coded event_type share is 0.2% (injury-light tercile) beside 0.04% Death-coded (quiet). Volume band: heavy.

What the Injury-mix reading shows for CAREFUSION 303, INC.

The standout signal for CAREFUSION 303, INC. is Injury-mix: 0.2% Injury-coded (injury-light) beside 0.04% Death-coded, on a heavy-book footprint.

As a heavy-book manufacturer, portfolio size and reporting obligations inflate absolute counts - pair CAREFUSION 303, INC. with device-family pages before treating company totals as a safety verdict. Event_type Death and Injury are one code per report; Patient Outcomes below use a separate FDA population.

Reports span 20 device types, led in this extract by Malfunction at 64,316 (99.7% of event_type total). Peak single-year volume reaches 53,359 reports across 17 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

64,508
Total Reports
25
Event-type Death
121
Injury Reports
20
Device Types

Event Types

Malfunction 64,316 (99.7%)
Injury 121 (0.2%)
37 (0.1%)
Death 25 (0.0%)
Other 8 (0.0%)
No answer provided 1 (0.0%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

62,709 (99.5%)
Other 125 (0.2%)
Required Intervention 52 (0.1%)
Life Threatening 32 (0.1%)
Death 26 (0.0%)
R 23 (0.0%)
Hospitalization 13 (0.0%)
O 10 (0.0%)
L 9 (0.0%)
H 5 (0.0%)
S 2 (0.0%)
Congenital Anomaly 2 (0.0%)
C 1 (0.0%)
Disability 1 (0.0%)

Yearly Trend

10
2010: 5
11
2011: 5
12
2012: 30
13
2013: 44
14
2014: 56
15
2015: 110
16
2016: 165
17
2017: 193
18
2018: 198
19
2019: 216
20
2020: 215
21
2021: 165
22
2022: 316
23
2023: 508
24
2024: 1,671
25
2025: 53,359
26
2026: 7,252